Influenza A virus A/California/122/2022 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere]
RxNorm 2675673

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2675673 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza A virus A/California/122/2022 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Influenza A virus A/California/122/2022 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere]
AUI:12875657
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Influenza A virus A/California/122/2022 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere]
(Atom ID: 12875657)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2675673
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12875657
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
2675673
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260504F
The specific version of the vocabulary provided by the source.
Update Date
May 04, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXTERM FORM
Prefilled Syringe
The RxTerm dose form name for this drug